Table 3.
Complete response rate according to compliance for treatment
| GNRI/sarcopenia risk | P | ||
|---|---|---|---|
| High cachexia risk | Low cachexia risk | ||
| CR in all patients | 33/71 (46.5) | 136/157 (86.6) | < 0.001 |
| CR in patients who completed treatment without DA | 17/22 (77.3) | 79/87 (90.8) | 0.132 |
| CR in patients who completed treatment with DA ≥ 75%a | 11/16 (68.8) | 39/42 (92.9) | 0.030 |
| CR in patients who completed treatment with DA < 75%b | 2/5 (40.0) | 15/16 (93.8) | 0.028 |
| CR in patients who early discontinued treatment | 3/28 (10.7) | 3/12 (25.0) | 0.341 |
aRelative dose intensity of cyclophosphamide and doxorubicin ≥75%
bRelative dose intensity of cyclophosphamide and/or doxorubicin < 75%
Abbreviations: GNRI Geriatric Nutritional Risk Index, CR complete response, DA dose adjustment